Trump Administration Approves Nvidia H200 AI Chip Sales to China Under New Export Rules 
BESI Reports Strong Q4-25 Orders Surge Driven by Data Center and Hybrid Bonding Demand 
Taiwan Issues Arrest Warrant for OnePlus CEO Over Alleged Illegal Recruitment Activities 
Trump Weighs Blocking Exxon Investment as Venezuela Deemed “Uninvestable” 
Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal 
Saks Global Files for Bankruptcy Protection Amid Mounting Luxury Retail Pressures 
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s 
U.S. Government Invests $1 Billion in L3Harris Rocket Motor Business to Secure Missile Supply Chain 
Anthropic Launches HIPAA-Compliant Healthcare Tools for Claude AI Amid Growing Competition 
Trump Considers Starlink to Restore Internet Access in Iran Amid Protests 
Nvidia Denies Upfront Payment Requirement for H200 AI Chips Amid China Export Scrutiny 
Amazon Reviews Supplier Costs as U.S.–China Tariffs Ease 
BlackRock to Cut Around 250 Jobs as CEO Larry Fink Pushes Strategic Shift 
HSBC Expands UAE Presence With New Asset Management Business and Onshore Funds 
Coca-Cola Shelves Costa Coffee Sale After Low Private Equity Offers 
SK Hynix to Invest $13 Billion in Advanced Chip Packaging Plant as AI Memory Demand Surges 
NYC Nurses Strike Shuts Down 10 Private Hospitals as 15,000 Demand Safer Staffing and Benefits 
BURLINGTON, Mass., March 31, 2017 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at 16th Annual Needham Healthcare Conference on Tuesday, April 4, 2017 at The Westin Grand Central, New York City, NY.
The Company is scheduled to present at 12:50 p.m. EDT.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.
Contact: LeMaitre Vascular, Inc. Investor Relations Steven Chehames +1-781-425-1659 [email protected]
